American Association Of Pharmaceutical Scientists Announces 1998 Award Winners
...disposition anddelivery, as well as mechanisms for ocular drug transport. He is an AAPS Fellowand served as AAPS President in 1996. Dr. Lee is a Professor and Chair of theDepartment of Pharmaceutical Sciences at the University of Southern California. AAPS Research Achievement Award in Analysis and Pharmace...... cervical spinal column, extremities) Auditory and ocular injuries -Tympanic membrane ruptured (typical) -Deafness/Tinnitus/Vertigo -Transient blindness/Photophobia-Conjunctivitis - Corneal damage -Retinal abnormalities (macular hole) - optic neuritis -Cataract "Lightning injuries are varied and take many ...UI researchers discover that aggressive cancer cells may make their own blood vessels
...ough the UI researchers focused their attention on ocular and skin melanoma,they have preliminary data suggesting that this phenomenon may occur in othertumors. The researchers are awaiting scientific peer review before they releaseany additional information. Because this study deals with new and novel conc...AAPS announces 1999 award winners
...icular focus in the use of bioadhesivepolymers and ocular drug disposition and delivery. He is professor of Pharmacy& Ophthalmology at the University of Wisconsin-Madison, and a past president ofboth AAPS and the Controlled Release Society. Sponsored by ZenecaPharmaceuticals, the AAPS Distinguished Pharma...Cancer-causing drug safe and effective in treating eye disease
....3 million people in the United States suffer from ocular inflammatory disorders such as uveitis, according to statistics on blindness and blinding diseases compiled by the University of Washington. Uveitis is estimated to cause 10 percent to 15 percent of blindness in this country....Treating eye pain may remove other migraine symptoms
...flamed trochlea. Injections produced relief of the ocular pain and associated migraine symptoms within 48 to 72 hours. Study author Julio Yangela Rodilla, MD, with the Headache Program, Fundacion Hospital Alcorcon, Madrid, Spain, said all five patients experienced relief following treatment, with one ...Long-term safety data on Xalatan presented
...ngle glaucoma, chronic angle closure glaucoma, and ocular hypertension. The most commonly reported side effects in eyes of patients treated with XALATAN for 6 months in clinical trials include eye irritation, eyelid redness, irritation of the clear front part surface of the eye, eyelid inflammation, darkeni...XALACOM more effective than Cosopt for IOP reduction in patients with glaucoma or ocular hypertens
...wice-daily in patients with open-angle glaucoma or ocular hypertension, according to a study presented at th...n 251 patients with primary open angle glaucoma or ocular hypertension was a randomized, parallel group, masked-evaluator, multicenter comparison of XALACOM ...Study finds intraocular pressure improved when switched to XALATAN from other monotherapy
...staglandin derivatives, for open angle glaucoma or ocular hypertension resulted in improved or maintained in...f 825 patients with primary open-angle glaucoma or ocular hypertension completed the ongoing, multicenter, prospective, open-label study. All patients admini...Light adjustable intraocular lenses may offer customized vision for cataract patients
...ing, inaccuracies in pre-operative measurements of ocular dimensions, or pre-existing corneal disorders such as astigmatism. With this technology, we can make power adjustments after the lens is in place, wound healing has occurred, and the eye is stabilized, said Daniel Schwartz, MD, UCSF associate profess...Study shows eye drops useful in preventing glaucoma
...race, and a family history of glaucoma, as well as ocular risk factors including elevated eye pressure, corneal thinness and certain characteristics in the anatomy of the optic nerve. "Glacoma is often referred to as the 'sneak thief of sight' because it often occurs with no pain or symptoms," said Gross, ...UC Davis study shows eye drops delay onset of glaucoma in people at higher risk
... such as older age and African descent, as well as ocular risk factors, such as higher eye pressure, anatomy...act in preserving the sight of many Americans with ocular hypertension by using proven therapies already at their disposal for glaucoma care, said James Brand...Eye drops can delay onset of glaucoma
...f 40 and 80. All had elevated pressure in the eye ocular hypertension but did not have glaucoma. About half (817) were randomly selected to use eye drops each day. The other patients (819) were closely monitored by eye specialists for a minimum of five years. Patients who received treatment were given com...Eye drops delay onset of glaucoma in people at higher risk
... such as older age and African descent, as well as ocular risk factors, such as higher eye pressure, certain...en-angle glaucoma. For the purposes of this study, ocular hypertension which can be diagnosed by an eye care professional was defined as pressure of 24 mm H...'Power nap' prevents burnout; morning sleep perfects a skill
... So how might a nap help? Recordings of brain and ocular electrical activity monitored while napping revealed that the longer 1-hour naps contained more than four times as much deep, or slow wave sleep and rapid eye movement (REM) sleep than the half-hour naps. Subjects who took the longer naps also spent...Schepens is recipient of the most National Eye Institute funds in 2001
...atments. Stem cells to regenerate retinal tissue, ocular gene therapy, angiogenesis and the use of small molecules to inhibit eye inflammation are just some of the efforts underway. Innovative new devices to help compensate for vision loss and improve quality of life are also being developed and tested at ...Having dry eye before LASIK surgery is a risk factor for severe dry eye after surgery
...onths and 1 year after surgery. Tear function and ocular surface condition were more compromised after LASI... follow up. The authors conclude: "With the proper ocular surface management, patients with dry eye can be good candidates for LASIK. However, our results al...FINAL ALERT: RPB Science Writers Seminar in Eye Research to be held in Washington, DC Sept. 22-25
...YE CANCERS: NEW ANSWERS. Current therapies for ocular cancers often take a major toll: severe vision loss. Reason: lack of specificity i.e. not only tumor cells but normal eye cells take the hit. But all that's likely to change with the emergence of a new breed of "designer" drugs, small, readily del...$2 per dose vs. $1500 per dose: One doctor develops new therapy for macular degeneration
...iochemical analysis of lipids in Bruch's membrane, ocular imaging, and intraocular inflammation....American Academy of Ophthalmology announces new award, its highest honor
...betic retinopathy, retinal detachments, and severe ocular injuries. Most recently, he has developed a treatment for age-related maculopathy that involves the surgical translocation of the central part of the macula to a healthy part of the retina to help the patient recover or maintain visual acuity. Dr. Sc...